Japan's Eisai amps up in China with new manufacturing plant

Eisai is drawing a bigger target on China with plans for a new manufacturing plant near Suzhou. The Japanese drugmaker will use the plant to tap growing demand in that country, as well as an export base for other emerging markets in Asia. Report

Suggested Articles

J&J's talc woes deepened Friday after the FDA turned up "sub-trace" levels of asbestos one bottle of the company's baby powder,…

Another major drugmaker is recalling in the U.K. 10 batches of its Zantac generics because they contain a possible carcinogen.

With diagnosis rates on the rise, Pfizer's Vyndaqel franchise could collect $157 million in 2019 U.S. sales, well above consensus, SVB Leerink says.